Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

High-street pharmacies are ready to provide the jabs on the NHS and boost take-up for all, says senior pharmacist ...

TikTok creator Janelle Rohner revealed she is taking a GLP-1 medication for weight loss — despite selling $200 courses to ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...

A decision is expected in the fourth quarter of 2025.

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...

Health and wellness influencer Janelle Rohner had been documenting her weight loss journey long before she admitted to using ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

Get your weekly dose of the top news that matters in our newsletter.